Showing 1 to 12 of 30 results


UnitedHealth Stock: Buffett's Endorsement Fuels Potential \$600 Rebound
Warren Buffett's endorsement of UnitedHealth Group (UNH) has renewed investor confidence, shifting focus to a potential stock rebound from roughly \$300 to over \$600 based on projected 2026 earnings of \$24 per share and a return to a 25x earnings multiple; however, risks remain, including persiste...
UnitedHealth Stock: Buffett's Endorsement Fuels Potential \$600 Rebound
Warren Buffett's endorsement of UnitedHealth Group (UNH) has renewed investor confidence, shifting focus to a potential stock rebound from roughly \$300 to over \$600 based on projected 2026 earnings of \$24 per share and a return to a 25x earnings multiple; however, risks remain, including persiste...
Progress
48% Bias Score


UnitedHealth Group Faces Federal Investigation, $288 Billion Stock Loss
UnitedHealth Group, a major US health insurer, is facing a federal criminal investigation for potential Medicare fraud, leading to the abrupt resignation of its CEO, Andrew Witty, and a staggering $288 billion stock value loss in one month.
UnitedHealth Group Faces Federal Investigation, $288 Billion Stock Loss
UnitedHealth Group, a major US health insurer, is facing a federal criminal investigation for potential Medicare fraud, leading to the abrupt resignation of its CEO, Andrew Witty, and a staggering $288 billion stock value loss in one month.
Progress
60% Bias Score


Hemsley Returns as UnitedHealth CEO Amidst Financial Uncertainty
After Andrew Witty's sudden resignation, 72-year-old Stephen J. Hemsley returned as UnitedHealth Group CEO on Tuesday, citing a need to improve operational efficiency and address rising medical costs, resulting in a suspension of the company's 2025 financial outlook.
Hemsley Returns as UnitedHealth CEO Amidst Financial Uncertainty
After Andrew Witty's sudden resignation, 72-year-old Stephen J. Hemsley returned as UnitedHealth Group CEO on Tuesday, citing a need to improve operational efficiency and address rising medical costs, resulting in a suspension of the company's 2025 financial outlook.
Progress
48% Bias Score


UnitedHealth's Earnings Miss Triggers Market Downturn
UnitedHealth Group's stock plummeted 22.4% Thursday after missing earnings targets, dragging the Dow down 1.3%; a federal judge ruled against Google on antitrust charges; and the IMF lowered its global growth forecast amid trade uncertainties.
UnitedHealth's Earnings Miss Triggers Market Downturn
UnitedHealth Group's stock plummeted 22.4% Thursday after missing earnings targets, dragging the Dow down 1.3%; a federal judge ruled against Google on antitrust charges; and the IMF lowered its global growth forecast amid trade uncertainties.
Progress
56% Bias Score


Mangione Thanks Supporters Amidst Public Debate Over Healthcare
Luigi Mangione, arrested for the December murder of UnitedHealth CEO Brian Thompson in New York, expressed gratitude for the outpouring of support, while a poll shows 41% of 18-29 year-olds viewing the murder as somewhat acceptable, reflecting criticism of the healthcare system.
Mangione Thanks Supporters Amidst Public Debate Over Healthcare
Luigi Mangione, arrested for the December murder of UnitedHealth CEO Brian Thompson in New York, expressed gratitude for the outpouring of support, while a poll shows 41% of 18-29 year-olds viewing the murder as somewhat acceptable, reflecting criticism of the healthcare system.
Progress
56% Bias Score


Major Banks Lead Strong Start to 2025 Earnings Season
The 2025 corporate earnings season begins this week, with major U.S. banks like JPMorgan Chase, Goldman Sachs, and Wells Fargo, alongside UnitedHealth, set to report fourth-quarter results; analysts predict nearly 12% year-over-year earnings growth, potentially the strongest since 2021.
Major Banks Lead Strong Start to 2025 Earnings Season
The 2025 corporate earnings season begins this week, with major U.S. banks like JPMorgan Chase, Goldman Sachs, and Wells Fargo, alongside UnitedHealth, set to report fourth-quarter results; analysts predict nearly 12% year-over-year earnings growth, potentially the strongest since 2021.
Progress
28% Bias Score

Justice Department Launches Criminal Probe into UnitedHealth's Medicare Billing
The Department of Justice is conducting a criminal investigation into UnitedHealth Group, the nation's largest private health insurer, for potential Medicare fraud related to its Medicare Advantage program, following earlier civil investigations and reports of doctors being pressured to submit claim...

Justice Department Launches Criminal Probe into UnitedHealth's Medicare Billing
The Department of Justice is conducting a criminal investigation into UnitedHealth Group, the nation's largest private health insurer, for potential Medicare fraud related to its Medicare Advantage program, following earlier civil investigations and reports of doctors being pressured to submit claim...
Progress
44% Bias Score

UnitedHealth Group Faces Crushing Crisis: CEO Resigns Amidst Medicare Fraud Investigation and Stock Plummet
UnitedHealth Group, a major US health insurer, faces a severe crisis including its CEO's sudden resignation, withdrawal of financial guidance due to escalating medical costs, and a federal investigation into potential Medicare fraud, resulting in a massive $288 billion stock value loss and intense i...

UnitedHealth Group Faces Crushing Crisis: CEO Resigns Amidst Medicare Fraud Investigation and Stock Plummet
UnitedHealth Group, a major US health insurer, faces a severe crisis including its CEO's sudden resignation, withdrawal of financial guidance due to escalating medical costs, and a federal investigation into potential Medicare fraud, resulting in a massive $288 billion stock value loss and intense i...
Progress
56% Bias Score

UnitedHealth Group Faces Class-Action Lawsuit Over Alleged Misleading Statements
Investors are suing UnitedHealth Group for allegedly misleading them about the impact of negative publicity surrounding the death of its CEO and a Senate report on high claim denials, causing a significant stock drop and investor losses.

UnitedHealth Group Faces Class-Action Lawsuit Over Alleged Misleading Statements
Investors are suing UnitedHealth Group for allegedly misleading them about the impact of negative publicity surrounding the death of its CEO and a Senate report on high claim denials, causing a significant stock drop and investor losses.
Progress
48% Bias Score

Lawyers Challenge Death Penalty in UnitedHealth CEO Murder Case
Luigi Mangione's lawyers are challenging the U.S. government's decision to seek the death penalty for the murder of UnitedHealth Group executive Brian Thompson, arguing the decision was politically motivated and violated government protocols; the case awaits Mangione's plea in federal court.

Lawyers Challenge Death Penalty in UnitedHealth CEO Murder Case
Luigi Mangione's lawyers are challenging the U.S. government's decision to seek the death penalty for the murder of UnitedHealth Group executive Brian Thompson, arguing the decision was politically motivated and violated government protocols; the case awaits Mangione's plea in federal court.
Progress
56% Bias Score

UnitedHealth Data Breach Affects 190 Million Americans
A ransomware attack on UnitedHealth's Change Healthcare unit in February 2024 compromised the personal and medical data of 190 million Americans, marking the largest such breach in U.S. history and exposing individuals to identity theft and financial fraud.

UnitedHealth Data Breach Affects 190 Million Americans
A ransomware attack on UnitedHealth's Change Healthcare unit in February 2024 compromised the personal and medical data of 190 million Americans, marking the largest such breach in U.S. history and exposing individuals to identity theft and financial fraud.
Progress
44% Bias Score

Dow Jones Stocks Poised for Growth in 2025: Merck and Nvidia Lead the Way
Wall Street analysts predict strong gains for select Dow Jones stocks in 2025, with Merck leading at 32% projected upside due to its Keytruda drug and pipeline, while Nvidia projects 28% growth despite recent market corrections; other pharma stocks show mixed outlooks.

Dow Jones Stocks Poised for Growth in 2025: Merck and Nvidia Lead the Way
Wall Street analysts predict strong gains for select Dow Jones stocks in 2025, with Merck leading at 32% projected upside due to its Keytruda drug and pipeline, while Nvidia projects 28% growth despite recent market corrections; other pharma stocks show mixed outlooks.
Progress
40% Bias Score
Showing 1 to 12 of 30 results